AIM IMMUNOTECH INC (AIM)

US00901B1052 - Common Stock

0.19  0 (-0.58%)

After market: 0.1962 +0.01 (+3.26%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
135K
-17.18%
141K
4.44%
202K
43.26%
151.5K
-25.00%
1.798M
1,086.80%
3.858M
114.57%
9.848M
155.26%
51.553M
423.49%
118.27M
129.41%
227.59M
92.43%
312.19M
37.17%
EBITDA
YoY % growth
-16.284M
-14.00%
-19.667M
-20.77%
-31.678M
-61.07%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-17.059M
-13.60%
-19.923M
-16.79%
-31.916M
-60.20%
-21.601M
32.32%
-22.175M
-2.66%
-27.672M
-24.79%
-39.398M
-42.38%
-8.79M
77.69%
43.5M
594.88%
128.74M
195.95%
194.1M
50.77%
Operating Margin
-12,636.30%-14,129.79%-15,800.00%-14,258.00%-1,233.31%-717.26%-400.06%-17.05%36.78%56.57%62.17%
EPS
YoY % growth
-0.40
20.00%
-0.40-0.60
-50.00%
-0.34
43.33%
-0.41
-21.78%
-0.46
-10.98%
-0.54
-16.48%
-0.12
77.36%
0.59
583.33%
1.74
196.55%
2.56
47.09%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.12
53.38%
-0.11
7.42%
-0.11
-177.75%
-0.11
-65.70%
-0.11
12.50%
Revenue
Q2Q % growth
68.175K
4.88%

-100.00%
101K
102.00%

-100.00%
101K
48.15%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-5.847M
58.25%
-5.656M
1.36%
-5.656M
-53.11%
-5.656M
-26.00%
-5.656M
3.26%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.06
60.00%
-0.100.0436.63%
Q2 2024
Q2Q % growth
-0.04
60.00%
-0.120.0867.89%
Q1 2024
Q2Q % growth
-0.12
-50.00%
-0.120.00-3.31%
Q4 2023
Q2Q % growth
-0.26
-188.89%
-0.15-0.11-71.62%
Q3 2023
Q2Q % growth
-0.16
-23.08%
-0.11-0.05-44.01%
Q2 2023
Q2Q % growth
-0.10 -0.110.019.99%
Q1 2023
Q2Q % growth
-0.08 -0.110.0327.99%
Q4 2022
Q2Q % growth
-0.09
25.00%
-0.120.0325.74%
Q3 2022
Q2Q % growth
-0.13
-62.50%
-0.09-0.04-51.43%
Q2 2022
Q2Q % growth
-0.10
16.67%
-0.08-0.02-32.01%
Q1 2022
Q2Q % growth
-0.08 -0.07-0.01-13.15%
Q4 2021
Q2Q % growth
-0.12
-33.33%
-0.09-0.03-39.78%
Q3 2021
Q2Q % growth
-0.08 -0.080.00-5.61%
Q2 2021
Q2Q % growth
-0.12
-9.09%
-0.08-0.04-42.58%
Q1 2021
Q2Q % growth
-0.08
63.64%
-0.090.018.61%
Q4 2020
Q2Q % growth
-0.09
32.84%
-0.07-0.02-21.52%
Q3 2020
Q2Q % growth
-0.08
92.92%
-0.080.004.95%
Q2 2020
Q2Q % growth
-0.11
89.72%
-0.10-0.01-8.91%
Q1 2020
Q2Q % growth
-0.22
92.44%
-0.15-0.07-48.51%
Q4 2019
Q2Q % growth
-0.13
89.85%
-0.370.2464.14%
Q3 2019
Q2Q % growth
-1.13
48.64%
-0.98-0.15-15.34%
Q2 2019
Q2Q % growth
-1.07 -1.720.6537.68%
Q1 2019
Q2Q % growth
-2.91 -2.22-0.69-30.96%
Q4 2018
Q2Q % growth
-1.32 -3.111.7957.57%
Q3 2018
Q2Q % growth
-2.20 -2.670.4717.49%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
35K
-23.91%
17.675K17.325K98.02%
Q2 2024
Q2Q % growth
50K
19.05%
11.787K38.213K324.21%
Q1 2024
Q2Q % growth
40K
-18.37%
40K%
Q4 2023
Q2Q % growth
65K
16.07%
36.865K28.135K76.32%
Q3 2023
Q2Q % growth
46K
119.05%
17.675K28.325K160.25%
Q2 2023
Q2Q % growth
42K
40.00%
23.23K18.77K80.80%
Q1 2023
Q2Q % growth
49K
48.48%
49K%
Q4 2022
Q2Q % growth
56K
12.00%
185.507K-129.507K-69.81%
Q3 2022
Q2Q % growth
21K
-36.36%
152.843K-131.843K-86.26%
Q2 2022
Q2Q % growth
30K
-42.31%
139.047K-109.047K-78.42%
Q1 2022
Q2Q % growth
33K
17.86%
704.475K-671.475K-95.32%
Q4 2021
Q2Q % growth
50K
19.05%
37.037K12.963K35.00%
Q3 2021
Q2Q % growth
33K
-8.33%
350.47K-317.47K-90.58%
Q2 2021
Q2Q % growth
52K
30.00%
354.51K-302.51K-85.33%
Q1 2021
Q2Q % growth
28K
-37.78%
353.167K-325.167K-92.07%
Q4 2020
Q2Q % growth
42K
-16.00%
357.207K-315.207K-88.24%
Q3 2020
Q2Q % growth
36K
-40.98%
363.6K-327.6K-90.10%
Q2 2020
Q2Q % growth
40K
37.93%
339.027K-299.027K-88.20%
Q1 2020
Q2Q % growth
45K 338.017K-293.017K-86.69%
Q4 2019
Q2Q % growth
50K
-79.17%
462.247K-412.247K-89.18%
Q3 2019
Q2Q % growth
61K
60.53%
74.235K-13.235K-17.83%
Q2 2019
Q2Q % growth
29K
-3.33%
64.64K-35.64K-55.14%
Q1 2019
Q2Q % growth

-100.00%
73.73K-73.73K-100.00%
Q4 2018
Q2Q % growth
240K 101K139K137.62%
Q3 2018
Q2Q % growth
38K 50.5K-12.5K-24.75%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-9.09% -9.09% 0% 19.2%
RevenueN/A N/A 0% 12.5%